Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

We'll examine a selection from our screener results. Overview: Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for musculoskeletal disorders ...

How Do Unusual Items Influence Profit? To properly understand Globus Medical's profit results, we need to consider the US$200m expense attributed to unusual items. While deductions due to unusual ...

Globus Medical (GMED) came out with quarterly earnings of $0.68 per share, missing the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.72 per share a year ago.

Pennsylvania-based Globus Medical, Inc. company is primarily focused on products for knee and hip procedures, as well as robotic and imaging systems. However, its main business is providing a wide ...

Globus Medical reported its financial results for Q1 2025, revealing a miss on both earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.68, falling short of the ...

AUDUBON, Pa. (AP) — AUDUBON, Pa. (AP) — Globus Medical Inc. (GMED) on Thursday reported first-quarter earnings of $75.5 million. On a per-share basis, the Audubon, Pennsylvania-based company ...

Across the recent three months, 6 analysts have shared their insights on Globus Medical GMED, expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

For the quarter ended March 2025, Globus Medical (GMED) reported revenue of $598.12 million, down 1.4% over the same period last year. EPS came in at $0.68, compared to $0.72 in the year-ago quarter.

Globus Medical has a 1 year low of $54.48 and a 1 year high of $94.93. The company has a market capitalization of $7.64 billion, a price-to-earnings ratio of 74.05, a P/E/G ratio of 1.61 and a ...